CarthroniX Completes Convertible Note Financing

/PRNewswire/ -- CarthroniX, Inc., a California-based startup developing novel small molecule modulators of the cell surface receptor gp130, today announced the...

Related Keywords

California ,United States ,Ron Ellis ,Pacira Biosciences ,Hassan Serhan ,Prnewswire Carthronix Inc ,Pacira Biosciences Inc ,Carthronix Inc ,Drug Administration ,Proceeds Will Support Pre Clinical Development ,Clinical Advancement ,Lead Candidate ,Moderate Knee ,Investigational New Drug ,Carthronix ,Nc ,